• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

business development

Headshot of Lundbecks CEO Charl van Zyl
Pharma

How Lundbeck’s CEO aims to keep firm ‘punching above its weight’

Lundbeck’s CEO, Charl van Zyl, told Fierce that he is confident the company can prove its mettle as a “neuroscience challenger.”
Fraiser Kansteiner Aug 21, 2026 11:30am
AZ

AZ leans on cancer, rare disease muscle in solid Q2

Jul 27, 2026 10:21am
Sanofi

Sanofi announces limited changes to its revamped executive team

Jul 21, 2026 1:35pm
Pfizer
Favicon Fierce Biotech

A 5-month sprint: Inside Pfizer's $10B deal with Innovent

Jun 21, 2026 10:41pm
Astellas

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm
handshake deal shake hand arrows ok yes

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Apr 6, 2026 8:37am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings